Palatin Technologies, Inc.
Melanocortin receptor-specific peptide with C-terminal naphthylalanine
Last updated:
Abstract:
Melanocortin receptor-specific peptides with a C-terminal naphthylalanine of the formula: ##STR00001## where R.sub.4, R.sub.7, R.sub.9, R.sub.11, R.sub.18, R.sub.20, R.sub.21a, R.sub.21b, R.sub.21c and R.sub.22 are as defined in the claims, compositions and formulations including the peptides of the foregoing formula or salts thereof, and methods of preventing, ameliorating or treating melanocortin receptor-mediated or responsive diseases, indications, conditions and syndromes.
Status:
Grant
Type:
Utility
Filling date:
17 Jan 2018
Issue date:
14 Jul 2020